References
- Sakaguchi S., Sakaguchi N. Organ-specific autoimmune disease induced in mice by elimination of T cell subsets. Journal of Immunology 1989; 142: 471–80
- Classen J. B., Shevach E. M. Evidence that cyclosporine treatment during pregnancy predisposes offspring to develop autoantibodies. Transplantation 1991; 51: 1052–7
- Classen J. B. The timing of immunization affects the development of diabetes in rodents. Autoimmunity 1996; 24: 137–45
- Classen D. C., Classen J. B. The timing of pediatric immunization and the risk of insulin-dependent diabetes mellitus. Infectious Diseases in Clinical Practice 1997; 6(7), October, 1997, fin press]
- Classen J. B., Classen D. C. Incidence of IDDM in Germany is not higher than predicted. Diabetes Care 1997; 20(11), November, 1997, [In press]
- Classen J. B., Classen D. C. Vaccines modulate type I diabetes. Diabetologia 1996; 39: 500–1
- Classen J. B. Diabetes epidemic follows hepatitis B immunization program. New Zealand Medical Journal 1996; 109: 195
- Classen J. B. The diabetes epidemic and the hepatitis B vaccine. New Zealand Medical Journal 1996; 109: 366
- Classen J. B. Method and composition for an early vaccine to protect against both infectious diseases and chronic immune mediated disorders or their sequela. PCT patent application, PCT/US94/08825, 1994
- Urdahl K. B., Pardoll D. M., Jenkins M. K. Cyclosporin A inhibits positive selection and delays negative selection in alpha beta TCR transgenic mice. Journal of Immunology 1994; 152: 2853–9
- Classen J. B., Shevach E. M. Post-thymec-tomy organ-specilic autoimmunity: enhancement by cyclosporine A and inhibition by IL-2. Autoimmunity 1993; 15: 55–9
- Dahlquist G., Frisk G., Svanberg L., Forsgren L., Didherolom H. Indications that maternal Cox-sackie B virus infection during pregnancy is a risk factor for childhood-onset IDDM. Diabetologia 1995; 38: 1371–3
- Pilarski L. M., Yacyshyn B. R., Lazarovits A. L. Analysis of peripheral blood lymphocyte populations and immune function from children exposed to cyclosporine or to azathioprine in utero. Transplantation 1994; 57: 133–44
- Baarsma R., Kamps W. A. Immunological responses in an infant after cyclosporine A exposure during pregnancy. European Journal of Pediatrics 1993; 152: 476–7
- Claris O., Picaud J. C, Brazier J. L., Salle B. L. Pharmacokinetics of cyclosporin A in 16 newborn infants of renal or cardiac transplant mothers. Development Pharmacology and Therapeutics 1993; 20: 180–5
- Halsey N., Galazka A. The effect of DTP and oral poliomyelitis immunization schedules initiated at birth to 12 weeks of age. Bulletin of the World Health Organization 1985; 63: 1151–69
- Kurikka S., Kayhty H., Peltola H., Saarinen L., Eskola J., Makela P. H. Neonatal immunization: response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. Pediatrics 1995; 95: 815–22